Tixagevimab-Cilgavimab: COVID-19 Pre-Exposure Prophylaxis.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical journal of oncology nursing"
DOI: 10.1188/22.cjon.479-482
Abstract: Tixagevimab-cilgavimab is the only nonvaccine drug currently authorized in the United States for the prevention of COVID-19 infection in individuals who are moderately to severely immunocompromised or unable to receive COVI. read more here.
Keywords: cilgavimab covid; exposure prophylaxis; tixagevimab cilgavimab; cilgavimab ... See more keywords